Transitoepiteelikasvain

Transitoepiteelikasvain, also known as transitional cell carcinoma, is a type of cancer that originates in the transitional epithelium, which lines various organs such as the urinary bladder, ureters, and renal pelvis. It is the most common type of bladder cancer and the second most common type of kidney cancer. Transitional cell carcinoma is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Symptoms may include hematuria (blood in the urine), frequency of urination, and pain or discomfort during urination.

The exact cause of transitional cell carcinoma is not fully understood, but risk factors include smoking, exposure to certain chemicals, and a history of chronic bladder infections. The disease is typically diagnosed through imaging tests such as cystoscopy and biopsy. Treatment options depend on the stage of the cancer and may include surgery, chemotherapy, radiation therapy, or a combination of these treatments. In some cases, the cancer may be managed with active surveillance or immunotherapy.

Transitional cell carcinoma is a significant health concern due to its high incidence and the potential for aggressive behavior. Early detection and prompt treatment are crucial for improving outcomes. Research is ongoing to better understand the disease and develop more effective treatments.